Lightbits Labs Named Storage Company of the Year and Receives Storage Hardware Award for SuperSSD NVMe/TCP at SDC Awards
3.12.2019 16:00:00 EET | Business Wire | Press release
At the recent SDC Awards gala here, Lightbits Labs took home two prestigious awards, Storage Company of the Year and Hardware Innovation of the Year. Lightbits received the nod for storage company of the year for its software defined storage (SDS) solution that brings hyperscale efficiency to on-premise cloud infrastructure with low-latency composable storage. Lightbits’ SuperSSD NVMe/TCP Storage Server , the World’s First Ultra-High Capacity, High Performance SSD Storage Appliance solution was selected as the most innovative hardware solution.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191203005290/en/
Lightbits Labs takes home storage company of the year and wins storage hardware award for SuperSSD NVMe/TCP at the SDC Awards. Posing with the awards from left to right are: Kam Eshghi, Chief Strategy Officer, Shirley Kirzner, Eran Kirzner, Chief Executive Officer and Co-Founder, George Agasandian, Director of Solutions Engineering and Co-Founder, Ofir Efrati, VP of Engineering and Co-Founder, Shaul Galia, Chief Operations Officer, and Miki Avni, Chief Financial Officer. (Photo; Business Wire)
The SDC (Storage, Digitalization + Cloud) Awards, now in their 10th year, recognize and reward success in the products and services that are foundational to digital transformation. Lightbits received the honor for how the company is reimagining hyperscale storage for next-generation applications.
Co-founded by veteran Israeli entrepreneur and founder of Annapurna Avigdor Willenz, Lightbits introduced three groundbreaking technologies in its first year out of stealth mode: LightOS, LightField, and SuperSSD. The company was cited for its leadership in delivering software defined solution that runs on commodity hardware to disaggregate storage and compute over standard networks, allowing them to scale independently (increasing flexibility & efficiency) and maximizing resource utilization (lowering TCO) while delivering performance that is similar to direct-attached SSDs. Lightbits pioneered NVMe/TCP so its solution is easy to deploy at scale.
“Being recognized by our peers and voters from around the globe for this award highlights the increasingly important role of practical, smart and forward-thinking storage solutions for true digital transformation,” said Eran Kirzner, co-founder and CEO at Lightbits Labs. “Companies are responsible for vast amounts of data through both public and private clouds, and the volume of data continues to grow exponentially. We’re proud that our solutions are being recognized for their transformational role in addressing the data storage challenges that are so prevalent in enterprises today.”
In March 2019, Lightbits introduced its groundbreaking LightOS and LightField. The LightOS software and LightField storage acceleration card provide a high-performance, end-to-end disaggregation solution that can scale without requiring any changes to data center clients or network infrastructure. They were the industry’s first NVMe/TCP solutions to provide a Global Flash Translation Layer (GFTL) running over high-performance standard networks. The solutions allow private clouds and software-as-a-service (SaaS) providers to capitalize on the application performance of using local NVMe SSDs with the simplicity and efficiency of hyperscale solutions.
As trailblazers of a new storage paradigm, Lightbits’ solutions are successfully being used in industry-leading cloud data centers around the globe. The company is gaining industry recognition for its ground-breaking solutions and has received three industry awards over the past six months.
Lightbits Labs Resources
For additional information, contact info@lightibtslabs.com
About Lightbits Labs™
Lightbits Labs, founded in 2016, is remaking modern cloud infrastructure on a global scale. The company’s mission is to reinvent the way storage and networking are conducted in data centers. As trailblazers in this field, its solutions are successfully being used in industry-leading private cloud and enterprise data centers around the globe. With strategic investors including Dell Technology Capital and Micron, and with investments from Chairman and co-founder Avigdor Willenz, Lip-Bu Tan (CEO of Cadence and chairman of Walden International) and Marius Nacht, (Co-Founder and Chairman of Check Point Software), Lightbits Labs is disaggregating storage and compute to improve performance and TCO. Learn more at www.lightbitslabs.com or contact us at info@lightbitslabs.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005290/en/
Contact information
Alan Ryan/Marianne Dempsey
alanryan@rainierco.com/ mdempsey@rainierco.com
508-475-0025, ext. 116 or 115
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom